EMBARK: a randomized, controlled trial comparing three approaches to reducing diabetes distress and improving HbA1c in adults with type 1 diabetes
Hessler DM, Fisher L, Guzman S, et al.
Diabetes Care. Pub. online 29 May 2024.
Leggi
Tirzepatide for weight reduction in chinese adults with obesity: the SURMOUNT-CN randomized clinical trial
Zhao L, Cheng Z, Lu Y, et al.
JAMA. Pub. online 31 May 2024.
Leggi
Medical artificial intelligence and human values
Yu KH, Healey E, Leong TY, et al.
N Engl J Med. Pub. online 30 May 2024.
Leggi
Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
Perkovic V, Tuttle KR, Rossing P, et al.
N Engl J Med. Pub. Online 24 May 2024.
Leggi
Prospective associations between breast feeding, metabolic health, inflammation and bone density in women with prior gestational diabetes mellitus
Hebeisen I, Gonzalez Rodriguez E, Arhab A, et al.
BMJ Open Diabetes Res Care. Pub. Online 21 May 2024.
Leggi
Identification and validation of gestational diabetes subgroups by data-driven cluster analysis
Salvatori B, Wegener S, Kotzaeridi G, et al.
Diabetologia. Pub. Online 27 May 2024.
Leggi
Plozasiran, an RNA Interference agent targeting APOC3, for mixed hyperlipidemia
Ballantyne CM, Vasas S, Azizad M, et al.
N Engl J Med. Pub. Online 28 May 2024.
Leggi
Risk of neonatal hypoglycemia in infants of mothers with gestational glucose intolerance
Andrews C, Maya J, Schulte CCM, et al.
Diabetes Care. Pub. Online 24 May 2024.
Leggi
Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes
Riester MR, Zullo AR, Joshi R, et al.
Diabetes Obes Metab. Pub. Online 23 May 2024.
Leggi